Abstract Library

#3028 Pancreatic Neuroendocrine Neoplasms: Dissecting the Molecular Heterogeneity

Introduction: Pancreatic neuroendocrine neoplasms (PNENs) are a group of rare but biologically and clinically heterogeneous neoplasms with variable patient outcomes. Little is known about the molecular differences between PNENs and the biologic significance of such divergence.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Yang K, Kalloger S, Aird J, Lee M, Colborne S,

Keywords: Pancreatic neuroendocrine neoplasms, Exome, Transcriptome, Proteome,

#2127 Detection of Bone Metastases at FDOPA-PET in Small-Intestine (si)NET: Prevalence and Associated Factors

Introduction: FDOPA-PET has high sensitivity to detect siNET and associated metastases.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: de Mestier L

Authors: de Mestier L, Deleval N, Hentic O, Palazzo M, Lebtahi R,

Keywords: small intestine NET, bone metastases, PET, FDOPA-PET,

#2108 Molecular Characterization of Primary and Metastatic Pancreatic Neuroendocrine Tumors

Introduction: Pancreatic neuroendocrine tumours (PNETs) are a heterogeneous group of rare pancreatic neoplasms often diagnosed with distant metastases, which are associated with significantly poorer prognosis. Recurrent somatic mutations, chromosomal aberrations and gene expression signatures in PNETs have been described, but the clinical significance of these molecular changes is still poorly understood, and the clinical outcomes of PNET patients remain highly variable.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Yang K, Wong H, Shen Y, Colborne S, Kalloger S,

Keywords: pancreatic neuroendocrine tumor, metastasis, primary tumor, proteomics, transcriptomics,

#2083 Plasma Protein Kallikrein-14 Strongly Predicts Pronounced Chromogranin A (CgA) Response in Small Intestinal Neuroendocrine Tumor (NET) Patients after Somatostatin Analog (SSA) Treatment: The Nordic EXPLAIN Biomarker Study

Introduction: Predicting treatment response at an early stage in the treatment algorithm for NET is highly desirable.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Kjellman M

Authors: Kjellman M, Knigge u, Welin S, Grønbæk H, Thiis-Evensen E,

Keywords: Plasma Protein Biomarker,

#829 On the Benign Side of Malignancy: How Neuroendocrine Tumors are Experienced by Patients and Their Family Carers

Introduction: Neuroendocrine tumors (NETs) are rare, slow-growing neoplasia with variable clinical presentations. Due to their non-specific symptoms and a lack of diagnostic tools, late diagnosis is common. There is little research relating to NETs as experienced by both patients and family carers.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Kall S

Authors: Kall S, Spichiger E, Stoll H,

Keywords: neuroendocrine tumors, rare diseases, qualitative research ,